{"id":2050,"date":"2016-10-01T01:00:00","date_gmt":"2016-10-01T00:00:00","guid":{"rendered":"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/"},"modified":"2018-10-20T18:40:22","modified_gmt":"2018-10-20T16:40:22","slug":"toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue","status":"publish","type":"post","link":"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/","title":{"rendered":"Toxicit\u00e9 digestive des immunoth\u00e9rapies anti PD1: Une pathologie nouvelle et polymorphe peu connue"},"content":{"rendered":"<p><strong>2016<\/strong><\/p>\n<p><em>Sarra Oumrani, Isablle Rosa, Emma Ferrand, Alix Portal, Anne Laure Audrain, Laurent Costes, Herv\u00e9 Hag\u00e8ge<\/em><\/p>\n<p><strong>Gastroent\u00e9rologie <\/strong>&#8211; \u00a02016-05-01 &#8211;\u00a0CO &#8211;<\/p>\n<p>________________________________<\/p>\n<p>L\u2019utilisation de nouvelles immunoth\u00e9rapies anti PD1 a montr\u00e9 son efficacit\u00e9 dans le cadre du traitement de m\u00e9lanomes m\u00e9tastatiques ou de carcinomes bronchiques. De nombreux effets ind\u00e9sirables ont \u00e9t\u00e9 d\u00e9crits notamment digestifs tels qu\u2019une diarrh\u00e9e dans 11 \u00e0 19% des cas et une colite MICI-like dans 1% des cas apr\u00e8s utilisation du Nivolumab. Nous rapportons quatre cas d\u2019atteintes digestives polymorphes document\u00e9es imputables directement aux anti PD1.<\/p>\n<p>Il s\u2019agit de 4 patients hospitalis\u00e9s dans le service d\u2019h\u00e9pato-gastroent\u00e9rologie pour une atteinte digestive s\u00e9v\u00e8re. Trois patients avaient re\u00e7u un traitement de 2 \u00e0 11 perfusions de Nivolumab et une patiente avait re\u00e7u 7 cures de Pembrolizumab pour un ad\u00e9nocarcinome bronchique stade IV. Il s\u2019agissait d\u2019une femme de 71 ans et trois hommes de 68, 64 et 65 ans. La pr\u00e9sentation clinique \u00e9tait dans un cas une intol\u00e9rance alimentaire totale avec des \u00e9pigastralgies et une diarrh\u00e9e chronique d\u2019installation rapide chez les 3 autres cas. Les sympt\u00f4mes \u00e9taient survenus en moyenne 3 mois apr\u00e8s l\u2019instauration du traitement. Tous les patients ont eu une perte de poids de plus de 10%, (en moyenne de  7,5 kg), ayant n\u00e9cessit\u00e9 une assistance nutritionnelle dans 3 cas.  Les l\u00e9sions endoscopiques \u00e9taient dans un cas une gastrite ulc\u00e9r\u00e9e n\u00e9crotique compliqu\u00e9e de st\u00e9nose duod\u00e9nale sans atteinte colique et dans un autre cas une colite aigue grave RCH-like. Chez 2 patients, les explorations endoscopiques \u00e9taient normales mais l\u2019histologie avait mis en \u00e9vidence une atrophie villositaire totale dans 1 cas et \u00e0 une colite lymphocytaire dans 1 cas. Les patients ont tous re\u00e7u des cortico\u00efdes en premi\u00e8re intention, permettant une \u00e9volution favorable chez 2 patients. Chez les 2 patients ayant les l\u00e9sions endoscopiques s\u00e9v\u00e8res, un traitement par anti TNF a \u00e9t\u00e9 r\u00e9alis\u00e9 en 2\u00e8me ligne sans efficacit\u00e9. Un traitement de 3\u00e8me ligne par vedolizumab a permis l\u2019am\u00e9lioration clinique rapide et endoscopique des 2 patients. Concernant l\u2019imputabilit\u00e9 du nivolumab, il n\u2019existait pas d\u2019autre traitement concomitant chez l\u2019ensemble des patients et 3 des patients avaient b\u00e9n\u00e9fici\u00e9 d\u2019explorations digestives ant\u00e9rieures normales. Chez le patient ayant une atrophie villositaire, les Ac anti TG \u00e9taient n\u00e9gatifs ainsi que l\u2019HLA DQ2DQ8.<\/p>\n<p>Conclusion<br \/>\nLes r\u00e9sultats des nouvelles immunoth\u00e9rapies anti PD1 sont prometteurs, au prix d\u2019effets ind\u00e9sirables pouvant \u00eatre graves et pouvant n\u00e9cessiter des th\u00e9rapeutiques lourdes. Les atteintes digestives secondaires aux anti PD1 peuvent \u00eatre polymorphes et vari\u00e9es. Il est primordial de sensibiliser les praticiens aux effets ind\u00e9sirables digestifs de ces nouveaux m\u00e9dicaments.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2016 Sarra Oumrani, Isablle Rosa, Emma Ferrand, Alix Portal, Anne Laure Audrain, Laurent Costes, Herv\u00e9 Hag\u00e8ge Gastroent\u00e9rologie &#8211; \u00a02016-05-01 &#8211;\u00a0CO &#8211; ________________________________ L\u2019utilisation de nouvelles immunoth\u00e9rapies anti PD1 a montr\u00e9 son efficacit\u00e9 dans le cadre du traitement de m\u00e9lanomes m\u00e9tastatiques ou de carcinomes bronchiques. De nombreux effets ind\u00e9sirables ont \u00e9t\u00e9 d\u00e9crits notamment digestifs tels qu\u2019une [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[4],"tags":[27],"class_list":["post-2050","post","type-post","status-publish","format-standard","hentry","category-gastroenterologie","tag-27"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Toxicit\u00e9 digestive des immunoth\u00e9rapies anti PD1: Une pathologie nouvelle et polymorphe peu connue - Abstracts des congr\u00e8s de l&#039;ANGH<\/title>\n<meta name=\"description\" content=\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Toxicit\u00e9 digestive des immunoth\u00e9rapies anti PD1: Une pathologie nouvelle et polymorphe peu connue - Abstracts des congr\u00e8s de l&#039;ANGH\" \/>\n<meta property=\"og:description\" content=\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\" \/>\n<meta property=\"og:url\" content=\"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/\" \/>\n<meta property=\"og:site_name\" content=\"Abstracts des congr\u00e8s de l&#039;ANGH\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ANGH-2136322560030484\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-10-01T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-20T16:40:22+00:00\" \/>\n<meta name=\"author\" content=\"abstracts\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"abstracts\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/\"},\"author\":{\"name\":\"abstracts\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1\"},\"headline\":\"Toxicit\u00e9 digestive des immunoth\u00e9rapies anti PD1: Une pathologie nouvelle et polymorphe peu connue\",\"datePublished\":\"2016-10-01T00:00:00+00:00\",\"dateModified\":\"2018-10-20T16:40:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/\"},\"wordCount\":471,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\"},\"keywords\":[\"2016\"],\"articleSection\":[\"Gastroenterologie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/\",\"url\":\"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/\",\"name\":\"Toxicit\u00e9 digestive des immunoth\u00e9rapies anti PD1: Une pathologie nouvelle et polymorphe peu connue - Abstracts des congr\u00e8s de l&#039;ANGH\",\"isPartOf\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#website\"},\"datePublished\":\"2016-10-01T00:00:00+00:00\",\"dateModified\":\"2018-10-20T16:40:22+00:00\",\"description\":\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\",\"breadcrumb\":{\"@id\":\"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/angh.net\/abstracts\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Toxicit\u00e9 digestive des immunoth\u00e9rapies anti PD1: Une pathologie nouvelle et polymorphe peu connue\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/angh.net\/abstracts\/#website\",\"url\":\"https:\/\/angh.net\/abstracts\/\",\"name\":\"Abstracts des congr\u00e8s de l&#039;ANGH\",\"description\":\"Base de donn\u00e9es des abstracts du congr\u00e8s depuis 2003\",\"publisher\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/angh.net\/abstracts\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\",\"name\":\"ANGH\",\"url\":\"https:\/\/angh.net\/abstracts\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg\",\"contentUrl\":\"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg\",\"width\":48,\"height\":18,\"caption\":\"ANGH\"},\"image\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ANGH-2136322560030484\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1\",\"name\":\"abstracts\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g\",\"caption\":\"abstracts\"},\"url\":\"https:\/\/angh.net\/abstracts\/author\/abstracts\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Toxicit\u00e9 digestive des immunoth\u00e9rapies anti PD1: Une pathologie nouvelle et polymorphe peu connue - Abstracts des congr\u00e8s de l&#039;ANGH","description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/","og_locale":"fr_FR","og_type":"article","og_title":"Toxicit\u00e9 digestive des immunoth\u00e9rapies anti PD1: Une pathologie nouvelle et polymorphe peu connue - Abstracts des congr\u00e8s de l&#039;ANGH","og_description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","og_url":"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/","og_site_name":"Abstracts des congr\u00e8s de l&#039;ANGH","article_publisher":"https:\/\/www.facebook.com\/ANGH-2136322560030484\/","article_published_time":"2016-10-01T00:00:00+00:00","article_modified_time":"2018-10-20T16:40:22+00:00","author":"abstracts","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"abstracts","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/#article","isPartOf":{"@id":"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/"},"author":{"name":"abstracts","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1"},"headline":"Toxicit\u00e9 digestive des immunoth\u00e9rapies anti PD1: Une pathologie nouvelle et polymorphe peu connue","datePublished":"2016-10-01T00:00:00+00:00","dateModified":"2018-10-20T16:40:22+00:00","mainEntityOfPage":{"@id":"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/"},"wordCount":471,"commentCount":0,"publisher":{"@id":"https:\/\/angh.net\/abstracts\/#organization"},"keywords":["2016"],"articleSection":["Gastroenterologie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/","url":"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/","name":"Toxicit\u00e9 digestive des immunoth\u00e9rapies anti PD1: Une pathologie nouvelle et polymorphe peu connue - Abstracts des congr\u00e8s de l&#039;ANGH","isPartOf":{"@id":"https:\/\/angh.net\/abstracts\/#website"},"datePublished":"2016-10-01T00:00:00+00:00","dateModified":"2018-10-20T16:40:22+00:00","description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","breadcrumb":{"@id":"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/angh.net\/abstracts\/toxicite-digestive-des-immunotherapies-anti-pd1-une-pathologie-nouvelle-et-polymorphe-peu-connue\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/angh.net\/abstracts\/"},{"@type":"ListItem","position":2,"name":"Toxicit\u00e9 digestive des immunoth\u00e9rapies anti PD1: Une pathologie nouvelle et polymorphe peu connue"}]},{"@type":"WebSite","@id":"https:\/\/angh.net\/abstracts\/#website","url":"https:\/\/angh.net\/abstracts\/","name":"Abstracts des congr\u00e8s de l&#039;ANGH","description":"Base de donn\u00e9es des abstracts du congr\u00e8s depuis 2003","publisher":{"@id":"https:\/\/angh.net\/abstracts\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/angh.net\/abstracts\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/angh.net\/abstracts\/#organization","name":"ANGH","url":"https:\/\/angh.net\/abstracts\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/","url":"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg","contentUrl":"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg","width":48,"height":18,"caption":"ANGH"},"image":{"@id":"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ANGH-2136322560030484\/"]},{"@type":"Person","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1","name":"abstracts","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g","caption":"abstracts"},"url":"https:\/\/angh.net\/abstracts\/author\/abstracts\/"}]}},"_links":{"self":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts\/2050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/comments?post=2050"}],"version-history":[{"count":0,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts\/2050\/revisions"}],"wp:attachment":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/media?parent=2050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/categories?post=2050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/tags?post=2050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}